2019 Sees Decline In EMA Drug Approval Recommendations
Agency Also Rejected 245 Proposed Brand Names
Executive Summary
The number of positive opinions given by the EMA’s CHMP has fallen to 66 this year from 84 in 2018.
You may also be interested in...
Beovu & Recarbrio Among Five Drugs On Track For EU-Wide Approval
Five new drugs have been recommended for EU approval at the latest meeting of European Medicines Agency’s drug evaluation committee.
42 New Substances Among 84 EU Approval Recommendations In 2018
The EMA’s CHMP recommended EU marketing authorization for a total of 84 new drugs in 2018, containing a total of 42 new active substances. They included the EU’s first two CAR-T cell therapies, Kymriah and Yescarta, which were also among the 21 orphan medicines to gain a positive opinion from the committee.
WHO Launches Twin-Track Procedure To Speed Access To Health Products
A procedure used to accelerate the approval of COVID-19 products during the pandemic is to be applied to all medicines using “synchronized and parallel, but otherwise entirely independent, processes,” the World Health Organization says.